Used primarily in research settings as a potent and selective antagonist for serotonin receptors, particularly the 5-HT2A subtype. It is valuable in neuroscience studies focusing on mood regulation, perception, and psychiatric disorders such as schizophrenia and depression. Due to its high affinity and specificity, it serves as a pharmacological tool to block 5-HT2A receptor activity in vitro and in vivo, helping to elucidate receptor function and signaling pathways. It may also support the development of novel therapeutics targeting serotonergic systems. Not intended for human use or clinical application.